Construction of mutant virus expressing hypo-glycosylated GP5 to develop inactivated vaccine.
Enhanced induction of serum neutralizing antibody response by inactivated mutant virus.
After homologous challenge, viremia was rapidly cleared in pigs immunized with the inactivated mutant virus.
Significantly reduced lymphocyte infiltration in lungs of pigs immunized with the inactivated mutant virus.